Filing Details
Centessa Pharmaceuticals plc (NASDAQ:CNTA) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event.
8k filedNASDAQ:CNTA
Centessa Pharmaceuticals plc (CNTA) Reports Material Event to SEC
Filing Details Centessa Pharmaceuticals plc (NASDAQ:CNTA) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event. Market…
Market Context
Centessa Pharmaceuticals plc's stock currently trades at $40.50 with a market capitalization of $3.7B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Centessa Pharmaceuticals plc's stock.
All SEC filings for Centessa Pharmaceuticals plc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CNTA Stock Page
Frequently Asked Questions
Where can I read CNTA's SEC filings?
Browse all filings on our CNTA SEC filings page.
What types of SEC filings does Centessa Pharmaceuticals plc file?
Public companies like Centessa Pharmaceuticals plc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.